Key facts
- It has raised $15.4M; the latest was Later Stage VC in Jul 2025.
- Notable investors include Cowin Capital, DPH Capital, Y.R.Delta Fund, Jinan International Medical Center Industrial Development, China Summit Capital — 10 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 10 names
- ·Watchlist + deal alerts for Farmove Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Farmove Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Farmove Medical
Manufacturer of biodegradable biomedical materials and regenerative medical products intended for tissue repair, structural reconstruction, and therapeutic interventions across multiple clinical disciplines. The company offers research-driven biomaterial design, material synthesis, product development, and clinical application support focused on musculoskeletal care, spinal intervention, neurological and craniofacial procedures, eye-related treatment, and aesthetic medicine, integrating regenerative medicine and synthetic biology approaches, enabling hospitals, surgeons, and medical institutions to long-term clinical integration across diverse surgical and therapeutic contexts.
- Sector
- Healthcare
- HQ
- Shanghai, China
- Founded
- 2014
- Employees
- 44
- Website
- medicalhuamu.com/
- Ownership
- Privately Held (backing)
Farmove Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Farmove Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Farmove Medical in its N-PORT filings yet. We sweep new filings monthly.